Test Price
2,800 AED✅ Home Collection Available
ITGA7 Gene Myopathy (Integrin Alpha‑7 Deficiency) Genetic Test in the UAE | From 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189‑accredited NGS processing and clinical interpretation.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection; Available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by a DHA‑licensed genetic counsellor.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ITGA7 Gene Myopathy Genetic Test uses Next‑Generation Sequencing to analyse the entire coding region of the ITGA7 gene for pathogenic variants associated with congenital muscular dystrophy due to integrin α7 deficiency. Early detection of this severe autosomal recessive disorder allows timely rehabilitation planning and family genetic counselling.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Regional Lab) |
|---|---|---|
| Precision | Full gene NGS with 99.9% analytical sensitivity | Targeted mutation panel, may miss novel variants |
| Methodology | Illumina NovaSeq X Plus, ISO 15189 alignments | Sanger sequencing of selected exons only |
| TAT & Price | 3–4 Weeks / 2800 AED | 6–8 Weeks / ~3500 AED |
Physician Insight & Safety Protocols
“This test represents a critical step in confirming the molecular diagnosis of integrin α7‑deficient congenital myopathy. While a negative result does not exclude the condition due to possible deep intronic or regulatory mutations, a positive finding enables precise prognostication and targeted management. I strongly recommend pairing this test with a comprehensive neuromuscular clinical exam.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Do not discontinue any prescribed medication or supplement without consulting your treating physician. Genetic testing is diagnostic, not a replacement for ongoing medical care.
Exclusion Criteria & Emergency Red Flags
- This test is not suitable as a standalone screen in asymptomatic adults without a clear family history of early‑onset myopathy – genetic counselling is mandatory.
- For children under 18 years, consent must be provided by the legal guardian in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- If the patient exhibits acute respiratory distress, dysphagia, or rapidly worsening motor function, seek immediate emergency care rather than waiting for test results.
- Do not delay urgent neurological interventions (e.g., cardiac monitoring, respiratory support) for test collection; coordinate with your neurologist.
Patient FAQ & Clinical Guidance
1. How accurate is this NGS test for ITGA7‑related myopathy, and can it detect all possible mutations?
With 99.9% analytical sensitivity and full‑gene coverage, this test detects >97% of reported pathogenic single‑nucleotide variants and small indels, although very large deletions or deep intronic changes may require supplementary methods like MLPA or whole genome sequencing. Results are interpreted by board‑certified molecular geneticists according to ACMG/AMP standards, ensuring clinical reliability for diagnosis and carrier screening.
2. Does health insurance cover the cost of this ITGA7 genetic test in the UAE?
Insurance coverage varies, but most major UAE insurers approve this test when referred by a DHA‑licensed genetic specialist. Contact our team via WhatsApp for direct pre‑approval verification before testing.
3. What is the sample collection process, and can it be done at home for a child with muscle weakness?
Our ISO‑certified home collection service uses a pain‑free, pediatric‑friendly approach: a certified phlebotomist visits between 8 AM and 11 PM to draw a minimal blood volume or collect a buccal swab/DNA FTA card, all under strict cold‑chain conditions. The procedure is completely safe and takes only 15 minutes, with no fasting or special preparation required. A pre‑genetic counselling session (included) must be completed first.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
Patient data is handled in strict accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA) under Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | ITGA7 Gene Myopathy (Integrin Alpha‑7 Deficiency) Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL EDTA) or Buccal Swab / DNA FTA Card |
| Methodology Used | Next‑Generation Sequencing (Illumina NovaSeq X Plus) with full gene coverage |
| ICD-10-CM Code | G71.2 |
| LOINC Code | 81252-6 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians